Log in

Aziyo Biologics Stock Forecast, Price & News

+0.16 (+1.48 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $10.98
50-Day Range N/A
52-Week Range
Now: $10.98
Volume6,556 shs
Average Volume192,373 shs
Market Capitalization$112.33 million
P/E RatioN/A
Dividend YieldN/A
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. It has additional offices in Roswell, Georgia; and Richmond, California
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Current SymbolNASDAQ:AZYO
Phone240 247 1147



Sales & Book Value

Annual SalesN/A



Market Cap$112.33 million
Next Earnings DateN/A
OptionableNot Optionable
+0.16 (+1.48 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AZYO News and Ratings via Email

Sign-up to receive the latest news and ratings for AZYO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aziyo Biologics (NASDAQ:AZYO) Frequently Asked Questions

Who are some of Aziyo Biologics' key competitors?

Who are Aziyo Biologics' key executives?

Aziyo Biologics' management team includes the following people:
  • Mr. Kevin L. Rakin M.B.A, M.S., Exec. Chairman (Age 59)
  • Mr. Ronald K. Lloyd, CEO, Pres & Director (Age 59)
  • Mr. Jeffry D. Hamet, VP of Fin.
  • Mr. Matthew B. Ferguson, Chief Financial Officer (Age 52)
  • Dr. Darryl Roberts Ph.D., Exec. VP of Operations & Product Devel. (Age 59)

When did Aziyo Biologics IPO?

(AZYO) raised $49 million in an IPO on Thursday, October 8th 2020. The company issued 2,900,000 shares at $16.00-$18.00 per share. Piper Sandler and Cowen served as the underwriters for the IPO and Cantor and Truist Securities ​ were co-managers.

What is Aziyo Biologics' stock symbol?

Aziyo Biologics trades on the NASDAQ under the ticker symbol "AZYO."

When does the company's quiet period expire?

Aziyo Biologics' quiet period expires on Tuesday, November 17th. Aziyo Biologics had issued 2,941,176 shares in its public offering on October 8th. The total size of the offering was $49,999,992 based on an initial share price of $17.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Aziyo Biologics?

Shares of AZYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aziyo Biologics' stock price today?

One share of AZYO stock can currently be purchased for approximately $10.98.

How big of a company is Aziyo Biologics?

Aziyo Biologics has a market capitalization of $112.33 million. Aziyo Biologics employs 150 workers across the globe.

What is Aziyo Biologics' official website?

The official website for Aziyo Biologics is www.aziyobiologics.com.

How can I contact Aziyo Biologics?

The company can be reached via phone at 240 247 1147.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.